Figure 5.
Cumulative probability of analyte retesting following initiation of (a) SHPT medication, (b) 25D medication, or (c) phosphate binders. CKD, chronic kidney disease; SHPT, secondary hyperparathyroidism.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.